LS Investment Advisors’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,120
Closed -$24K 1567
2020
Q2
$24K Hold
1,120
﹤0.01% 1361
2020
Q1
$26K Hold
1,120
﹤0.01% 1296
2019
Q4
$37K Hold
1,120
﹤0.01% 1398
2019
Q3
$36K Hold
1,120
﹤0.01% 1389
2019
Q2
$29K Hold
1,120
﹤0.01% 1448
2019
Q1
$28K Hold
1,120
﹤0.01% 1446
2018
Q4
$38K Hold
1,120
﹤0.01% 1346
2018
Q3
$40K Hold
1,120
﹤0.01% 1409
2018
Q2
$39K Hold
1,120
﹤0.01% 1404
2018
Q1
$38K Buy
1,120
+149
+15% +$4.71K ﹤0.01% 1376
2017
Q4
$37K Sell
971
-228
-19% -$9.1K ﹤0.01% 1393
2017
Q3
$45K Sell
1,199
-126
-10% -$4.45K ﹤0.01% 1392
2017
Q2
$49K Hold
1,325
﹤0.01% 1355
2017
Q1
$52K Sell
1,325
-122
-8% -$4.58K ﹤0.01% 1319
2016
Q4
$50K Buy
1,447
+94
+7% +$3.69K ﹤0.01% 1258
2016
Q3
$53K Hold
1,353
﹤0.01% 1195
2016
Q2
$51K Buy
1,353
+84
+7% +$2.81K ﹤0.01% 1203
2016
Q1
$49K Hold
1,269
﹤0.01% 1185
2015
Q4
$61K Hold
1,269
﹤0.01% 1065
2015
Q3
$50K Buy
1,269
+75
+6% +$3.19K ﹤0.01% 1140
2015
Q2
$51K Buy
+1,194
New +$47.6K ﹤0.01% 1161

Other funds holding NTUS

LS Investment Advisors's NTUS Position: Q3 2020 in Review

LS Investment Advisors sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 1,120 shares — an estimated $24K sold.

LS Investment Advisors first reported a position in NTUS in Q2 2015 and held it in 21 quarters. The position peaked at $61K in Q4 2015. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • LS Investment Advisors reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 1,120 Natus Medical Inc shares in Q3 2020, an estimated $24K.
  • LS Investment Advisors first reported a position in Natus Medical Inc in Q2 2015 and held it in 21 quarters.
  • LS Investment Advisors's Natus Medical Inc position peaked at $61K in Q4 2015.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.